Viewpoint: Medical MJ Resked: Implications for Insurance Coverage, Capacity and Compliance
The Department of Justice issued an order on April 23, rescheduling state-licensed medical marijuana and Food & Drug Administration-approved cannabis products to Schedule III of the Controlled Su…